Healthcare SPAC LifeSci Acquisition sets terms for $50 million IPO
LifeSci Acquisition, a blank check company targeting healthcare industry, announced terms for its IPO on Friday.
The New York, NY-based company plans to raise $50 million by offering 5 million units at a price of $10 and would command a market value of $63 million. Each unit consists of one share of common stock and one warrant exercisable at $11.50.
LifeSci Acquisition was founded in 2018 and plans to list on the Nasdaq under the symbol LSACU. Chardan Capital Markets is the sole bookrunner on the deal.
Investment Disclosure: Renaissance IPO ETF (symbol: IPO) Renaissance International ETF (symbol: IPOS)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
- Waste management company GFL Environmental relaunches IPO with lowered range of $20 to $21; adds $700 million equity unit offering
- High-growth medical device maker Inari Medical files for a $100 million IPO
- Preclinical biotech Passage Bio sets terms for $126 million IPO
- US IPO Week Ahead: One biotech to close out February